secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001104659-25-024505
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq to delist Avenue Therapeutics on March 19; stock to trade on OTC Markets
-------------------------------------------------------------------------------

- Nasdaq notified Company it will delist common stock effective at open on March 19, 2025.
- Delisting due to failure to maintain minimum $2.5M stockholders' equity per Nasdaq Rule 5550(b)(1).
- Company failed to meet conditions of Panel exception requiring disclosure of equity-increasing transactions by March 14.
- Common stock (ATXI) expected to begin trading on OTC Markets on March 19, 2025.
- Company will continue filing periodic reports with SEC but warns of uncertain trading liquidity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/0001104659-25-024505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/tm259546d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-024505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer